Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug.

[1]  J. Elefteriades,et al.  Contemporary Reviews in Cardiovascular Medicine Medical Therapy of Thoracic Aortic Aneurysms , 2011 .

[2]  M. Dake,et al.  Surgical Management of Descending Thoracic Aortic Disease: Open and Endovascular Approaches: A Scientific Statement From the American Heart Association , 2010, Circulation.

[3]  F. Biancari,et al.  The use of statins and fate of small abdominal aortic aneurysms. , 2008, Interactive cardiovascular and thoracic surgery.

[4]  Benjamin S. Brooke,et al.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. , 2008, The New England journal of medicine.

[5]  J. Cornuz,et al.  The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis , 2008, PloS one.

[6]  A. Daugherty,et al.  Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin converting enzyme inhibitors and aortic rupture: population based case control study. Lancet. 2006;368:659-665 , 2007 .

[7]  Donald A Redelmeier,et al.  Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study , 2006, The Lancet.

[8]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[9]  Eric M. Isselbacher,et al.  Thoracic and Abdominal Aortic Aneurysms , 2005, Circulation.

[10]  J. Elefteriades,et al.  Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. , 2004, The Annals of thoracic surgery.

[11]  J. Elefteriades.  Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. , 2002, The Annals of thoracic surgery.

[12]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[13]  B. Seifert,et al.  Chronic β-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection , 2001 .

[14]  P. Weissberg,et al.  Mechanisms modifying atherosclerotic disease - from lipids to vascular biology. , 1999, Atherosclerosis.

[15]  J. Elefteriades,et al.  Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. , 1999, The Annals of thoracic surgery.

[16]  J. Elefteriades,et al.  Procedures for estimating growth rates in thoracic aortic aneurysms. , 1998, Journal of clinical epidemiology.

[17]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[18]  R. Hubbard,et al.  Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. , 2009, British journal of clinical pharmacology.

[19]  John A Elefteriades,et al.  Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. , 2006, The Annals of thoracic surgery.

[20]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .